loader image

Clinical Operations

PharPoint’s clinical leadership team averages 20+ years of experience. We provide efficient study start up, quick enrollment, and quality execution, and offer remote study capabilities.

Biostatistics

All PharPoint biostatisticians have advanced degrees. Our wide range of services include study design, DMC support, and in-house custom programming.

Data Management

By performing data cleaning and reviews on a continuing basis during enrollment and study conduct, PharPoint’s clinical data management team can lock a database within 5 days of LPLV SDV.

Strategic Consulting

The cornerstone of PharPoint Research is our strategic consulting expertise, which is based on our consultants’ involvement in multiple successful development programs. 

BY THE NUMBERS
%
PharPoint's repeat business rate
+ studies
Participated in since 2006
years
Our leadership team's average industry experience
Regulatory submissions

Resources & Insights

Video
Virtual trials, COVID-19, & the future
Clinical Operations
Technology
39
Virtual trials, COVID-19, and the future of the industry As the FDA continues to develop evolving guidelines, our industry has experienced a sudden, paradigm shift towards hybrid and virtual trials, with telemedicine becoming the “norm” for patient interaction across a variety of therapeutic areas. PharPoint is a strong advocate of this approach as an option...
Video
COVID-19: Update from PharPoint Research
Press Release
132
COVID-19: Update from PharPoint Research As the situation with COVID-19 evolves, the PharPoint Research team is taking necessary precautions to ensure study operations continue uninterrupted. During this critical time in our industry, PharPoint remains fully dedicated, as always, to helping clients improve global health. Our leadership team has been closely monitoring the situation since the...
Video
Rare Disease Day 2020
Industry News
329

This February 29th, PharPoint acknowledges Rare Disease Day. We are relentless in supporting clients so that they may advance rare disease research and the approval of breakthrough treatments.

Speak with an expert